ACTU
Actuate Therapeutics, Inc. Common stock
stockNASDAQ
Market OpenNov 13, 2026 12:55:33 PM EST
0.30USD+1.284%(+0.00)96,543
Pre-marketNov 13, 2026 9:28:30 AM EST
0.3064USD+3.514%(+0.0104)
ACTU Financials
In Q2 FY 2026 (ended ), Actuate Therapeutics, Inc. Common stock (ACTU) reported net income of −$4.87M, operating cash flow of −$4.41M, and assets of $5.2M (filed ).
Loading financial statements…